International Advocacy

WASHINGTON, D.C. (Tuesday, April 19, 2011) - The Biotechnology Industry Organization (BIO) announced today that Dr. Jörg Reinhardt, CEO of Bayer HealthCare, will provide the keynote address at the BIO China International Conference to be held October 12-13 in Shanghai, China. The event will bring together biotechnology and pharmaceutical leaders to explore business opportunities with life science companies in China.

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year's BIO International Convention.

BIO is committed to increased access to biologic medicines for patients throughout the world. 

You might have heard that the Prince of Wales, just days after hosting the Royal Wedding, paid us a visit here in Washington.  Prince Charles, a long-time organic food advocate and self-described environmentalist, was here to speak at a Washington Post symposium on the Future of Food.

Prince Charles likes to talk about “sustainability” so much that he used a version of the word 32 times in his recent speech about farming at Georgetown University.

The world’s largest biotech hubs are busy planning their delegations’ visits to the  BIO International Convention  next month. The international program at the Convention will be one of the most robust to date, with International Case Studies, breakout sessions focused on globalization and Super Sessions focused on the emerging markets.

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year’s BIO International Convention.

Three biotech luminaries who have succeeded against all odds share their experiences building a biotech company from the ground up in Brazil, China and India.

As we celebrate World Health Day today, it is an opportunity to remember that vaccines represent one of the most important global health investments.

Fifteen years after Dolly, the first mammal to be cloned from an adult cell rather than an embryo, made headlines, the process of livestock cloning is increasingly gaining acceptance as a viable means of satisfying demand for sustainable food production.

Patent systems can provide an advantage to society by rewarding the development of new inventions, promoting the advancement of technology and protecting the investor.  Patents often are the most important, and sometimes only, asset of a biotech company. Patents and related rights must be obtained in a timely and predictable manner and the ability to enforce those patents is critical.

Overhauled BIOTradeStatus lets users search for the latest information on hundreds of products.

ISAAA data shows countries around the world have embraced agricultural biotechnology.

Bringing biotechs into global health R&D.

Letters, Testimony & Comments

February 22 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
February 8 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has...
February 1 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
February 1 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
January 18 2013
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has...

Press Releases

July 23 2012
Groups Issue Booklet to Help Biotechnology and Pharmaceutical Companies Identify Pipeline Medicines with Doping...
June 6 2012
Washington, DC and New York, NY, Wednesday, June 6, 2012 -The 4th Annual Scientific American Worldview Report and...
April 5 2012
WASHINGTON, D.C.(April 5, 2012)— Thought leaders from dozens of biotech and pharmaceutical corporations from...
October 5 2011
Washington, D.C. (October 5, 2011) – The Biotechnology Industry Organization (BIO) welcomed the transmission of...
April 28 2011
WASHINGTON, D.C. (Thursday, April 28, 2011) - Biofuel research and development companies will present progress in...